Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test
Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow
Liver Physiology
Liver Regeneration
Liver Histology
Factors Affecting Erythropoiesis
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Updated: Mar 24, 2026

Mouse Model of Metabolic Dysfunction-Associated Steatotic Liver Disease with Fibrosis
Published on: July 18, 2025
Xiaomeng Xie1, Leijie Wang2, Mingjie Yao2
1College of Public Health, Zhengzhou University, Zhengzhou 450001, China.
Red blood cell count varies significantly across liver diseases, being highest in hepatitis and lowest in cirrhosis. In cirrhosis patients, lower red blood cell counts correlate with more severe liver damage.
Area of Science:
Background:
Purpose of the Study:
Main Methods:
Main Results:
Conclusions: